| 摘要 |
<p>Methods and kits for diagnosing and prognosticating cancer via detection of EEF1A2 and/or EEF1A2 are provided. Also provided are methods for treating cancer via inhibition of expression and/or activity of EEF1A2 and screening assays to identify new anticancer agents based upon their ability to inhibit EEF1A2 expression and/or activity. The methods and kits of the present invention are particularly useful in the prognosis, diagnosis and treatment of ovarian, breast and colorectal cancer.</p> |
